BOSTON: A federal judge on Tuesday sentenced Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug and ordered that some of the US$40.1 million it agreed to pay to resolve a U.S. investigation go to the company's victims. U.S. District Judge William Young in Boston had in ...